PointClickCare Launches AI Platform to Unlock Long-Term Care Research Data
Event summary
- PointClickCare launched Study Buddy, an AI-powered research platform for long-term care data, on April 9, 2026.
- Study Buddy leverages PointClickCare’s dataset of 50+ data points per resident per day across extended stays.
- The platform aims to accelerate research, enabling grant submission-ready evidence in minutes instead of months.
- PointClickCare’s Life Sciences division is led by Jeff Wessinger, VP & GM.
The big picture
Long-term care research has historically been hampered by data accessibility and complexity. PointClickCare's Study Buddy addresses this by leveraging its extensive dataset and AI capabilities, potentially unlocking significant value in drug development, care optimization, and reimbursement strategies. This move signals a broader trend of healthcare providers monetizing their data assets and offering specialized analytics services to external researchers.
What we're watching
- Data Privacy
- The platform's reliance on de-identified patient data necessitates ongoing vigilance regarding HIPAA compliance and potential privacy risks, especially as AI models become more sophisticated and data linkage techniques advance.
- Adoption Rate
- The success of Study Buddy hinges on adoption by academic institutions and research organizations; limited uptake could indicate challenges in usability or a lack of perceived value despite the promised efficiency gains.
- Competitive Landscape
- While positioned as the first AI-powered LTC research platform, competitors may emerge or existing data analytics providers could adapt their offerings, potentially eroding PointClickCare’s first-mover advantage.
Related topics